US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Curanex Pharmaceuticals

0.4105

-0.0198-4.60%

Post-market: 0.4100-0.0005-0.12%17:45 EST

Volume:387.11K

Turnover:161.73K

Market Cap:11.63M

PE:-9.02

High:0.4760

Open:0.4527

Low:0.4012

Close:0.4303

52wk High:9.18

52wk Low:0.3760

Shares:28.34M

Float Shares:9.09M

Volume Ratio:2.41

T/O Rate:4.26%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0455

EPS(LYR):-0.0273

ROE:-17.38%

ROA:-10.08%

PB:0.81

PE(LYR):-15.06

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Curanex Pharmaceuticals Delays Quarterly Financial Report

Curanex Pharmaceuticals Faces Nasdaq Delisting Warning

Curanex Pharmaceuticals Receives Nasdaq Delisting Warning for Low Share Price

Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CURX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CURX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CURX\",,,,,undefined,":{"symbol":"CURX","market":"US","secType":"STK","nameCN":"Curanex Pharmaceuticals","latestPrice":0.4105,"timestamp":1764709200000,"preClose":0.4303,"halted":0,"volume":387109,"hourTrading":{"tag":"盘后","latestPrice":0.41,"preClose":0.4105,"latestTime":"17:45 EST","volume":1848,"amount":757.74216672,"timestamp":1764715557188},"delay":0,"floatShares":9093100,"shares":28340800,"eps":-0.04552,"marketStatus":"Post-Mkt","change":-0.0198,"latestTime":"12-02 17:49:07 EST","open":0.4527,"high":0.476,"low":0.40115,"amount":161734.82538293,"amplitude":0.173948,"askPrice":0.4265,"askSize":780,"bidPrice":0.41,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.04552,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1764723600000},"marketStatusCode":4,"adr":0,"listingDate":1756180800000,"exchange":"NASDAQ","adjPreClose":0.4303,"preHourTrading":{"tag":"盘前","latestPrice":0.4595,"preClose":0.4303,"latestTime":"09:15 EST","volume":6561,"amount":3108.1917375,"timestamp":1764684927120},"postHourTrading":{"tag":"盘后","latestPrice":0.41,"preClose":0.4105,"latestTime":"17:45 EST","volume":1848,"amount":757.74216672,"timestamp":1764715557188},"volumeRatio":2.406607},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CURX\",,,,,undefined,":{"symbol":"CURX","floatShares":9093100,"roa":"-10.08%","roe":"-17.38%","lyrEps":-0.027264,"volumeRatio":2.406607,"shares":28340800,"dividePrice":0,"high":0.476,"amplitude":0.173948,"preClose":0.4303,"low":0.40115,"week52Low":0.376,"pbRate":"0.81","week52High":9.1796,"institutionHeld":0,"latestPrice":0.4105,"committee":-0.772727,"eps":-0.04552,"divideRate":0,"volume":387109,"delay":0,"ttmEps":-0.04552,"open":0.4527,"prevYearClose":4,"prevWeekClose":0.4873,"prevMonthClose":0.4873,"prevQuarterClose":0.72,"fiveDayClose":0.466,"twentyDayClose":0.6722,"sixtyDayClose":7.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CURX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CURX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CURX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CURX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CURX","date":"2025-12-01","current":-9.452988,"percent":0.909091,"low":-596.14306,"twenty":-296.871717,"median":-46.540445,"eighty":-38.170637,"high":-8.812785,"avg":-130.411225,"sd":172.109735,"marketCap":13810477},"quantilePoints":[{"date":"2025-08-29","current":-343.821021,"twenty":-323.7357,"median":-309.527845,"eighty":-285.033231,"marketCap":144022500},{"date":"2025-09-05","current":-470.352457,"twenty":-397.745937,"median":-357.40162,"eighty":-309.364317,"marketCap":197025000},{"date":"2025-09-12","current":-522.424684,"twenty":-490.623986,"median":-396.156013,"eighty":-317.040593,"marketCap":227272500},{"date":"2025-09-19","current":-81.3514,"twenty":-518.980126,"median":-404.105632,"eighty":-309.03726,"marketCap":35390625},{"date":"2025-09-26","current":-44.190079,"twenty":-502.869283,"median":-357.40162,"eighty":-78.227506,"marketCap":19224187},{"date":"2025-10-03","current":-52.064896,"twenty":-490.623986,"median":-308.710204,"eighty":-52.935681,"marketCap":22650000},{"date":"2025-10-10","current":-48.094947,"twenty":-477.242127,"median":-89.974648,"eighty":-50.763274,"marketCap":20922937},{"date":"2025-10-17","current":-45.236453,"twenty":-457.103092,"median":-68.335176,"eighty":-47.069268,"marketCap":19679395},{"date":"2025-10-24","current":-42.064901,"twenty":-400.925784,"median":-54.241859,"eighty":-44.399354,"marketCap":18299662},{"date":"2025-10-31","current":-42.99649,"twenty":-384.761559,"median":-51.4271,"eighty":-44.033885,"marketCap":18704935},{"date":"2025-11-07","current":-39.915076,"twenty":-365.54998,"median":-50.763274,"eighty":-43.476372,"marketCap":17364415},{"date":"2025-11-14","current":-36.025849,"twenty":-337.125914,"median":-49.550198,"eighty":-42.216596,"marketCap":15672469},{"date":"2025-11-21","current":-9.181804,"twenty":-310.01843,"median":-47.092697,"eighty":-39.195744,"marketCap":11917311},{"date":"2025-11-28","current":-10.640411,"twenty":-308.710204,"median":-46.699426,"eighty":-38.202616,"marketCap":13810477},{"date":"2025-12-01","current":-10.640411,"twenty":-296.871717,"median":-46.540445,"eighty":-38.170637,"marketCap":13810477}],"updateTime":1764685571342},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CURX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584647671","title":"Curanex Pharmaceuticals Delays Quarterly Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2584647671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584647671?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:30","pubTimestamp":1763379027,"startTime":"0","endTime":"0","summary":"Curanex Pharmaceuticals Inc. has disclosed a delay in filing its quarterly report on Form 10-Q for the financial period ended September 30, 2025. The company cited that the report could not be filed on time without unreasonable effort or expense and expects to submit the filing within the allowed extension period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curanex Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL4NxqSb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURX","BK4007"],"gpt_icon":0},{"id":"2581190100","title":"Curanex Pharmaceuticals Faces Nasdaq Delisting Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2581190100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581190100?lang=en_us&edition=fundamental","pubTime":"2025-11-07 02:57","pubTimestamp":1762455452,"startTime":"0","endTime":"0","summary":"The latest update is out from Curanex Pharmaceuticals Inc. ( ($CURX) ). On November 5, 2025, Curanex Pharmaceuticals Inc. received a notification f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/curanex-pharmaceuticals-faces-nasdaq-delisting-warning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/curanex-pharmaceuticals-faces-nasdaq-delisting-warning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNQmain","CURX","NVIW.SI","SQQQ","USAW.SI","BK4007",".IXIC","NQmain","QID","TQQQ","USJW.SI","TSYW.SI","QLD","PSQ"],"gpt_icon":0},{"id":"2581019155","title":"Curanex Pharmaceuticals Receives Nasdaq Delisting Warning for Low Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2581019155","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581019155?lang=en_us&edition=fundamental","pubTime":"2025-11-07 02:41","pubTimestamp":1762454465,"startTime":"0","endTime":"0","summary":"Curanex Pharmaceuticals Inc. announced that it has received a notice from the Nasdaq Stock Market indicating that its common stock has closed below the required minimum bid price of $1.00 per share for 30 consecutive business days. This triggers a potential delisting issue under Nasdaq Listing Rule 5550. The company has 180 calendar days, until May 4, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days. During this period, Curanex's stock will continue to trade on the Nasdaq Capital Market under the symbol \"CURX\". If compliance is not regained, the company may be eligible for an additional 180-day extension or could face delisting.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDLbzL8P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CURX"],"gpt_icon":0},{"id":"2577365399","title":"Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement","url":"https://stock-news.laohu8.com/highlight/detail?id=2577365399","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577365399?lang=en_us&edition=fundamental","pubTime":"2025-10-22 19:00","pubTimestamp":1761130800,"startTime":"0","endTime":"0","summary":"Jericho, New York, Oct.  22, 2025  (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental-stage pharmaceutical company focused on discovering and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/22/3170944/0/en/Curanex-Pharmaceuticals-Inc-Engages-Strategic-Investor-Relations-to-Enhance-Investor-Communications-and-Engagement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURX","BK4007"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CURX\",params:#limit:6,delay:false,,,undefined,":[]}}